Ponvory: payments to doctors
Payments that named Ponvory as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.1M
- Providers
- 4,814
- Transactions
- 22,314
- Average per transaction
- $95
The per-transaction average — $95 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,814 providers the average total is $442, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Johnson & Johnson | $1,114,111 | 52.4% |
| Vanda Pharmaceuticals Inc. | $936,558 | 44.1% |
| Janssen Scientific Affairs, LLC | $44,191 | 2.1% |
| Janssen Global Services, LLC | $29,580 | 1.4% |
| Janssen Research & Development, LLC | $1,150 | 0.1% |